E169: Statistical Analysis: AVERT Vasopressin Trial

Throughout the course of modern medicine, old methods fall as new ones emerge safer, more reliable, better for patient outcomes, and more. Sims et al., Says this: "Resuscitation strategies that decrease the need for transfusions without increasing complications, therefore, would represent a clinically important innovation". Research is deep and results are shared throughout the world. One of the fastest-growing, most industry-related sections of medicine today is that of resuscitation. In this episode of The FlightBridgeED Podcast, the team of Dr. Jeff Jarvis and Mike Verkest from the highly-rated EMS LightHouse Project Podcast dissect the actual study from a statistical analysis standpoint. Is the data as good as it seems? Is it statistically significant? Is there a place for vasopressin administration early in the resuscitation phase within the realm of trauma-induced massive hemorrhage? Join them and find out! Don’t forget to rate and especially review wherever you got your podcasts. These reviews are especially key to keeping us high on the charts where your friends and colleagues can find us. Thank you for listening.